角膜移植市場規模、佔有率、成長分析（按類型、適應症、最終用戶、地區）- 2025-2032 年產業預測

2023 年角膜移植市場規模為 4.8999 億美元，預計將從 2024 年的 5.2674 億美元成長到 2032 年的 9.3943 億美元，預測期內（2025-2032 年）的複合年成長率為 7.5%。

根據美國美國衛生研究院 (NIH) 的最新研究結果，10% 至 15% 的圓錐角膜患者在治療過程中需要進行角膜移植。這凸顯了角膜植入在有效治療常見眼科疾病圓錐角膜方面的重要作用。此外，角膜失明是全球面臨的重大健康挑戰，在致盲原因中位列青光眼和白內障之後的第三位，影響全球約 1,000 萬人。這些數據表明，醫療保健系統需要角膜植入的創新解決方案和進步的巨大市場機會，以滿足大量患者的需求並在全球範圍內對抗角膜失明的後果。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 技術分析

角膜移植市場規模（按類型及複合年成長率）（2025-2032）

• 市場概覽
• 全層角膜移植
• 內皮角膜移植手術
• Descemet 膜剝離自動內皮角膜移植 (DSAEK)
• 角膜移植
• 角膜緣幹細胞移植
• 其他

角膜移植市場規模（按適應症和複合年成長率）（2025-2032）

• 市場概覽
• 真菌性角膜潰瘍
• 水痘角膜病變
• 圓錐角膜
• 角膜炎
• 角膜基質營養不良
• 其他

角膜移植市場規模（按最終用戶和複合年成長率） （2025-2032）

• 市場概覽
• 醫院
• 眼科診所
• 其他

角膜移植市場規模：依地區及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• CorneaGen（USA）
• Eversight（USA）
• Lions VisionGift（USA）
• Keramed Inc.（USA）
• EyeYon Medical（Israel）
• Aurolab（India）
• Presbia PLC（Ireland）
• Mediphacos（Brazil）
• DIOPTEX GmbH（Austria）
• AJL Ophthalmic SA（Spain）
• Florida Lions Eye Bank（USA）
• Ocular Systems Inc.（USA）
• Gebauer Medizintechnik GmbH（Germany）
• Tomey Corporation（Japan）
• SightLife（USA）
• Ampleye（Netherlands）
• Allotex（USA）
• Eye Bank Association of America（EBAA）（USA）
• Boston Keratoprosthesis（Boston KPro）（USA）
• IOPtima Ltd.（Israel）

結論和建議

Corneal Transplant Market size was valued at USD 489.99 million in 2023 and is poised to grow from USD 526.74 million in 2024 to USD 939.43 million by 2032, growing at a CAGR of 7.5% during the forecast period (2025-2032).

Recent findings from the National Institutes of Health (NIH) indicate that 10-15% of keratoconus patients require corneal implant procedures during their treatment journey. This highlights the critical role of corneal implants in effectively managing keratoconus, a prevalent ocular condition. Additionally, corneal blindness poses a significant global health challenge, ranking as the third leading cause of blindness after glaucoma and cataracts, impacting an estimated 10 million individuals worldwide. The data reveals a vital market opportunity for innovative solutions and advancements in corneal implants, as healthcare systems seek to address the needs of this substantial patient population and combat the consequences of corneal blindness on a global scale.

Top-down and bottom-up approaches were used to estimate and validate the size of the Corneal Transplant market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Corneal Transplant Market Segments Analysis

Global Corneal Transplant Market is segmented by Type, Indications, End-User and region. Based on Type, the market is segmented into Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), Corneal Graft, Corneal Limbal Stem Cell Transplant and Others. Based on Indications, the market is segmented into Fungal Corneal Ulcer, Bullous Keratopathy, Keratoconus, Keratitis, Corneal Stromal Dystrophies and Others. Based on End-User, the market is segmented into Hospital, Eye Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Corneal Transplant Market

One of the key market drivers for the global corneal transplant market is the rising prevalence of corneal diseases and conditions, such as keratoconus, corneal scarring, and endothelial dysfunction. As aging populations increase worldwide, the incidence of these eye disorders is also growing, leading to a higher demand for corneal transplantation procedures to restore vision and improve quality of life. Additionally, advancements in surgical techniques and technologies, such as femtosecond laser-assisted surgery and improved preservation methods for donor corneas, are enhancing the success rates of transplants, further propelling market growth as healthcare providers seek effective treatment options for patients.

Restraints in the Corneal Transplant Market

The growth of the corneal transplant market is hindered by several notable constraints, primarily the high costs associated with the procedure and a limited supply of donor corneas. The financial implications of corneal transplantation, which include expenses related to pre-operative evaluations, surgical procedures, and subsequent post-operative care, create a substantial economic burden for both patients and healthcare systems. These elevated costs can restrict access to treatment, especially in areas with limited healthcare resources, thereby impeding the overall expansion of the market. Additionally, the scarcity of available donor material further exacerbates these challenges, making it difficult for the market to flourish.

Market Trends of the Corneal Transplant Market

The corneal transplant market is witnessing remarkable growth driven by technological advancements and an increasing geriatric population. Innovative corneal implants are enhancing the treatment's efficacy for eye disorders, particularly as conditions like Fuchs' dystrophy become more prevalent among individuals over 40. The aging demographic underscores a rising need for effective solutions to age-related eye diseases, propelling market demand. Additionally, greater awareness of corneal health and improved surgical techniques further bolster this trend. As such, the corneal transplant market is positioned for continued expansion, characterized by a surge in transplantation procedures and the development of next-generation implants.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis

Global Corneal Transplant Market Size by Type & CAGR (2025-2032)

• Market Overview
• Penetrating Keratoplasty
• Endothelial Keratoplasty
• Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
• Corneal Graft
• Corneal Limbal Stem Cell Transplant
• Others

Global Corneal Transplant Market Size by Indications & CAGR (2025-2032)

• Market Overview
• Fungal Corneal Ulcer
• Bullous Keratopathy
• Keratoconus
• Keratitis
• Corneal Stromal Dystrophies
• Others

Global Corneal Transplant Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospital
• Eye Clinics
• Others

Global Corneal Transplant Market Size & CAGR (2025-2032)

• North America (Type, Indications, End-User)
  • US
  • Canada
• Europe (Type, Indications, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Indications, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Indications, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Indications, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• CorneaGen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eversight (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lions VisionGift (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Keramed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EyeYon Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurolab (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Presbia PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediphacos (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DIOPTEX GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AJL Ophthalmic S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Florida Lions Eye Bank (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ocular Systems Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gebauer Medizintechnik GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tomey Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SightLife (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ampleye (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allotex (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eye Bank Association of America (EBAA) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Keratoprosthesis (Boston KPro) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IOPtima Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations